Esofin® containing Esomeprazole sodium (equivalent to Esomeprazole base) as active ingredient is available in 40 mg steril powder for injection.
Esofin® injection is indicated for :
Gastric antisecretory treatment when the oral route is not possible, such as :
Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux.
Healing of gastric ulcers associated with NSAID therapy.
The short term maintenance of hemostasis and prevention of rebleeding in patients following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers
Esofin® Powder for IV injection 40 mg
Each vial contains: Esomeprazole sodium equivalent to Esomeprazole 40 mg.
Box, 1 vial @ 40 mg